Replies to post #218257 on Biotech Values

[DewDiligence]

Isn't RT002 is being talked about in the medical community in "what if" terms?

Yes, of course. RT002 is being discussed implicitly by asking injectors (e.g.) what they think about a botulinum-toxin product with an extended duration compared to Botox.

What can RVNC legally do/say before approval to possible patients/doctors? For that matter do you know what AGN can legally say and do?

As a practical matter, the FDA and DoJ are unlikely to pursue either company for merely talking book this far in advance of RT002’s commercial launch.